dermatology

Day three of the European Academy of Dermatology and Venereology (EADV) Congress 2026 delivered a series of notable developments in skin health research and clinical practice. A recap highlights five headline findings from the day, covering new study results and updates presented to dermatology specialists attending the meeting. The congress continues to draw international attention from clinicians and researchers.

New findings presented ahead of the EADV 2026 congress link climate change to shifts in skin disease patterns worldwide. Rising temperatures, increased UV exposure, and changing humidity are being associated with growing rates of skin cancer, eczema flare-ups, and the spread of tropical dermatological conditions to new regions. Dermatologists say the findings add to mounting evidence that global warming is affecting human health directly, and are calling for greater awareness and preparedness among skin health services.

A recent review finds that more than 40% of countries worldwide have reported climate-related changes in the prevalence or severity of skin diseases, with lower-income countries disproportionately affected. Rising temperatures, humidity and extreme weather are increasingly linked to conditions such as eczema, infections and heat-related dermatoses, prompting calls for greater dermatological preparedness.

HMP Global's learning network has published an educational piece on how longevity medicine may change dermatologic care. The article examines how longer lifespans and preventive, anti-aging approaches could influence how dermatologists treat skin health and aging-related conditions, pointing to a growing overlap between longevity science and everyday clinical practice in skin medicine.

The European Academy of Dermatology and Venereology's 2026 congress continued into its second day, with a recap highlighting six headline developments from the meeting. Coverage focuses on the key research presentations, clinical updates, and announcements emerging from the event, giving dermatology specialists a digest of the most notable news so far.

New reporting indicates climate change is associated with a worsening of skin diseases in 42% of countries worldwide. The finding suggests rising temperatures and environmental shifts may be aggravating dermatological conditions globally, adding to the growing list of health impacts attributed to a changing climate. Health professionals are watching how environmental factors continue to influence disease burden across regions.

New research indicates that climate change is having a major impact on skin health around the world. The findings suggest rising temperatures, pollution and environmental changes are contributing to skin conditions and other dermatological problems globally, adding a health dimension to the broader climate debate.

Dermatology experts are highlighting how a warming climate is aggravating skin conditions, with rising temperatures, increased UV exposure, pollution, and humidity linked to worsening eczema, acne, psoriasis, and other dermatological problems. The discussion reflects growing medical interest in the health impacts of climate change, as practitioners report more patients experiencing flare-ups tied to environmental shifts and extreme weather.

New reporting highlights that climate change is already having negative effects on skin health, with rising temperatures, increased UV exposure, and environmental changes associated with a range of skin conditions. Researchers warn these impacts are likely to grow as global warming continues, making dermatological health an emerging concern in climate discussions.

The European Academy of Dermatology and Venereology has begun its 2026 Congress, with day one yielding six headline developments in dermatology and venereology. Coverage highlights new clinical findings and treatment updates presented at the meeting, which brings together skin-health specialists from around the world. Attendees and medical media are summarising the most notable announcements as the congress continues.

CytoAgents presented new preclinical data on its investigational compound CTO1681 at the 2026 EADV Congress, the European Academy of Dermatology and Venereology's annual meeting. The company says the findings support the drug candidate's development potential in dermatology. Details of the data and the indication being targeted have not been broadly reported, and the announcement is drawing attention from investors and dermatology specialists following the congress presentation.

Kenvue-owned skincare brands Neutrogena and Aveeno, alongside hair-loss treatment Regaine, have presented new scientific evidence on how their science-backed ingredients support healthy skin and hair. The announcement highlights research into ingredient effectiveness, part of the companies' ongoing effort to promote dermatological credibility and product innovation to consumers and health professionals.